Pharmacokinetics Phase
Pharmacokinetics Phase - Related Videos
10:02
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
0 Views •
Cited by 59 •
2016
Rabbits are widely used to study the pharmacokinetics of intraocular drugs. We describe a method for conducting pharmacokinetic studies of intraocular drugs using rabbit eyes.
02:39
Phase Diagrams
0 Views •
2020
A phase diagram combines plots of pressure versus temperature for the liquid-gas, solid-liquid, and solid-gas phase-transition equilibria of a substance. These diagrams indicate the physical states that exist under specific conditions of pressure and temperature and also provide the pressure dependence of the phase-transition temperatures (melting points, sublimation points, boiling points). Regions or areas labeled solid, liquid, and gas represent single phases, while lines or curves represent...
02:31
Phase Transitions
0 Views •
2020
Whether solid, liquid, or gas, a substance's state depends on the order and arrangement of its particles (atoms, molecules, or ions). Particles in the solid pack closely together, generally in a pattern. The particles vibrate about their fixed positions but do not move or squeeze past their neighbors. In liquids, although the particles are closely spaced, they are randomly arranged. The position of the particles are not fixed—that is, they are free to move past their neighbors to occupy...
01:10
Pharmacokinetics: Overview
0 Views •
2023
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV) administration...
01:20
Pharmacokinetic Models: Overview
0 Views •
2024
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity. There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
FAQs
Each ADME process contributes a different change to drug concentration over time. Absorption brings the compound into the bloodstream, distribution describes its movement among tissues, metabolism chemically modifies it, and excretion removes it from the body. Their combined effects produce the concentration-time profile used to assess exposure and the expected duration of action.
Clearance and half-life provide complementary measures for interpreting how drug exposure changes over time. Together with the concentration-time profile, they help characterize how long the compound remains present and support decisions about dosing intervals. These measures also help connect pharmacokinetic findings with the duration of a drug’s effects in clinical research.
Bioavailability assessment and formulation comparisons show whether different product forms produce comparable drug exposure. Pharmacokinetic analysis can identify meaningful differences in the concentration-time profiles associated with those formulations. This information helps investigators interpret whether a formulation change may alter exposure and supports evidence-based evaluation of alternatives during clinical research.
A concentration-time profile shows how drug exposure changes as time passes after administration. Its pattern provides a framework for examining the combined influence of absorption, distribution, metabolism, and excretion rather than considering any one process in isolation. Researchers use this profile alongside measures such as clearance and half-life to interpret exposure and persistence.
Pharmacokinetic analysis is especially useful when researchers need to relate drug exposure to a practical dosing schedule. Findings on concentration changes, clearance, half-life, and duration of action can inform dosing intervals and safer dose selection. The same analysis supports interpretation of clinical outcomes by showing how exposure may contribute to observed effects.
Patient characteristics and drug interactions can change the exposure observed during clinical research, so results should not be interpreted independently of these factors. Comparing concentration-time findings across relevant patient groups or interaction conditions can reveal altered drug handling. Such comparisons help explain differences in clinical outcomes and support more appropriate dose selection.